Risk of postoperative complications among ulcerative colitis patients treated preoperatively with vedolizumab: a matched case-control study

Abstract Background Although biologic agents have revolutionized the medical management of severe ulcerative colitis (UC), there is considerable controversy regarding adverse effects of vedolizumab on surgical outcomes. We evaluated 30-day postoperative morbidity in UC patients undergoing abdominal...

Full description

Bibliographic Details
Main Authors: Jeong Yeon Kim, Karen Zaghiyan, Amy Lightner, Phillip Fleshner
Format: Article
Language:English
Published: BMC 2020-03-01
Series:BMC Surgery
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12893-020-00698-8